Insider Transactions in Q4 2021 at Kempharm, Inc (KMPH)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2021
|
Matthew R Plooster Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
$20,000
$8.44 P/Share
|
|
Nov 30
2021
|
David S Tierney Director |
BUY
Open market or private purchase
|
Direct |
2,000
+34.28%
|
$14,000
$7.79 P/Share
|
|
Nov 30
2021
|
Richard W Pascoe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+31.35%
|
$10,500
$7.88 P/Share
|
|
Nov 18
2021
|
Travis C Mickle President & CEO |
BUY
Open market or private purchase
|
Direct |
2,250
+5.8%
|
$18,000
$8.23 P/Share
|
|
Nov 18
2021
|
R. La Duane Clifton CFO & Treasurer |
BUY
Open market or private purchase
|
Direct |
510
+8.87%
|
$4,080
$8.29 P/Share
|